MedReleaf Australia has expanded its product range in Australia and New Zealand with the addition of three flowers and four resin cartridges.
The cartridges are all being released in Australia while the flowers will bolster the New Zealand options for prescribers.
MedReleaf Australia interim managing director Stanley Sack said both countries remain a “top priority” for the Aurora-owned business.
“We are deeply committed to our continued investment across the region,” he said. “As patient needs evolve, so does our responsibility to deliver high‑quality, diversified product formats that support prescribers in delivering better care.
“Our focus on quality and reliable supply reflects our dedication to ensuring patients have meaningful access to the products they depend on.”
Bioxyne/Breathe Life Sciences
Medicinal cannabis manufacturer Bioxyne has received its first order of GMP-manufactured psilocybin capsules for investigational use in treatment-resistant depression.
The order will see Bioxyne subsidiary Breathe Life Sciences (BLS) supply 250 doses to authorised prescribers in Queensland and Western Australia to treat approximately 60 patients over the next 12 months.
The capsules will also be used for exploratory research into other mental health conditions including anxiety disorders, substance use disorder and PTSD.
Bioxyne chief executive Sam Watson said BLS was “translating its psychedelic manufacturing capabilities into early commercial results and positive patient outcomes”.
“For Bioxyne, these initial supply agreements reflect disciplined execution at the outset of a multi-billion dollar opportunity with the potential to meaningfully improve quality of life for millions of people,” he said.
Greencare Clinic
Greencare Clinic has named Dr Aarons Rogers as its medical lead.
Chief executive George Moskos said the practitioner brings a combination of “clinical expertise, genuine care, a warm energy and thoughtful leadership”.
“His guidance will play a vital role in supporting our practitioners and ensuring patients continue to receive safe, high-quality care throughout their natural healthcare journey,” Moskos said.